Radiation therapy firm iCAD announced that more than 1,000 early-stage breast cancer patients have been treated with intraoperative radiation therapy (IORT) using the company's Xoft Axxent electronic brachytherapy system.
The growing adoption and utilization of iCAD's Xoft system further validates that IORT is an attractive alternative for the treatment of early-stage breast cancer, according to the firm.
A multicenter clinical trial evaluating the safety, efficacy, and cosmetic outcomes associated with IORT for early-stage breast cancer with Xoft is currently underway at hospitals across the U.S., iCAD said.
